These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68 related articles for article (PubMed ID: 8361030)
1. [An evaluation of tumor markers and risk factors in mass screening for various cancers]. Fujimoto H; Sasaki Y; Kawamura T; Ishimori A; Yanagiya T; Saita T Rinsho Byori; 1993 Jun; 41(6):642-8. PubMed ID: 8361030 [TBL] [Abstract][Full Text] [Related]
2. [Clinical preventive medicine in cancer diagnosis--proposal for a new cancer diagnostic system in an aging society]. Ishimori A Rinsho Byori; 1993 Jun; 41(6):617-24. PubMed ID: 8361026 [TBL] [Abstract][Full Text] [Related]
3. Cancer high-risk subjects identified by serum pepsinogen tests: outcomes after 10-year follow-up in asymptomatic middle-aged males. Yanaoka K; Oka M; Mukoubayashi C; Yoshimura N; Enomoto S; Iguchi M; Magari H; Utsunomiya H; Tamai H; Arii K; Ohata H; Fujishiro M; Takeshita T; Mohara O; Ichinose M Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):838-45. PubMed ID: 18398025 [TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness analysis for determining optimal cut-off of immunochemical faecal occult blood test for population-based colorectal cancer screening (KCIS 16). Chen LS; Liao CS; Chang SH; Lai HC; Chen TH J Med Screen; 2007; 14(4):191-9. PubMed ID: 18078564 [TBL] [Abstract][Full Text] [Related]
6. Ovarian cancer tumor marker behavior in asymptomatic healthy women: implications for screening. Crump C; McIntosh MW; Urban N; Anderson G; Karlan BY Cancer Epidemiol Biomarkers Prev; 2000 Oct; 9(10):1107-11. PubMed ID: 11045795 [TBL] [Abstract][Full Text] [Related]
7. The usefulness of gastric mass screening using serum pepsinogen levels compared with photofluorography. Yoshihara M; Sumii K; Haruma K; Kiyohira K; Hattori N; Tanaka S; Kajiyama G; Shigenobu T Hiroshima J Med Sci; 1997 Jun; 46(2):81-6. PubMed ID: 9232936 [TBL] [Abstract][Full Text] [Related]
8. [Clinical evaluation on an enzyme immunoassay kit for basic fetoprotein (BFP). (2) Comparison and combination of BFP with other tumor markers]. Ishii M; Hattori N; Kato T; Mochizuki M; Kamidono S; Sawabu N; Kawada Y; Kawai T; Abe O; Ohkura H Gan To Kagaku Ryoho; 1988 Jul; 15(7):2115-23. PubMed ID: 2456040 [TBL] [Abstract][Full Text] [Related]
9. [Detection of gastric preneoplastic lesions with serum levels of pepsinogen in Chilean subjects]. Fernández F JI; de Aretxabala U X; Santander D R; Sabah T S; Maira S J; Navarro R A; Planzer D M; Gómez L F; Etchart M; Gallegos I; Torrens X; Fasce P G; Reydet I Rev Med Chil; 2007 Dec; 135(12):1519-25. PubMed ID: 18357351 [TBL] [Abstract][Full Text] [Related]
10. Does PSA velocity predict prostate cancer in pre-screened populations? Schröder FH; Roobol MJ; van der Kwast TH; Kranse R; Bangma CH Eur Urol; 2006 Mar; 49(3):460-5; discussion 465. PubMed ID: 16442212 [TBL] [Abstract][Full Text] [Related]
11. [Current advancement of assay of tumor markers and the perspective in future]. Kawamura T Nihon Rinsho; 1996 Jun; 54(6):1642-8. PubMed ID: 8691623 [TBL] [Abstract][Full Text] [Related]
12. Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies. Cao Q; Ran ZH; Xiao SD J Dig Dis; 2007 Feb; 8(1):15-22. PubMed ID: 17261130 [TBL] [Abstract][Full Text] [Related]
14. Screening and monitoring for bladder cancer: refining the use of NMP22. Ponsky LE; Sharma S; Pandrangi L; Kedia S; Nelson D; Agarwal A; Zippe CD J Urol; 2001 Jul; 166(1):75-8. PubMed ID: 11435827 [TBL] [Abstract][Full Text] [Related]
15. Atherosclerotic risk factors and renal function in the elderly: the role of hyperfibrinogenaemia and smoking. Results from the Italian Longitudinal Study on Ageing (ILSA). Baggio B; Budakovic A; Perissinotto E; Maggi S; Cantaro S; Enzi G; Grigoletto F; Nephrol Dial Transplant; 2005 Jan; 20(1):114-23. PubMed ID: 15572387 [TBL] [Abstract][Full Text] [Related]
16. [Developing a hospital-based high risk scoring model and screening strategy for pancreatic cancer]. Deng RX; Lu XH; Wang L; Li H; Qian JM; Yang AM; Zhong SX; Guo XZ; Zhou L; Wu X; Yang XO; Jiang WJ Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(29):2038-42. PubMed ID: 16313796 [TBL] [Abstract][Full Text] [Related]
19. A new fecal calprotectin test for colorectal neoplasia. Clinical results and comparison with previous method. Johne B; Kronborg O; Tøn HI; Kristinsson J; Fuglerud P Scand J Gastroenterol; 2001 Mar; 36(3):291-6. PubMed ID: 11305517 [TBL] [Abstract][Full Text] [Related]
20. Tumor type M2-pyruvate-kinase levels in pleural fluid versus plasma in cancer patients: a further tool to define the need for invasive procedures. Elia S; Massoud R; Guggino G; Cristino B; Cortese C; De Massimi AR; Zenobi R Eur J Cardiothorac Surg; 2008 Apr; 33(4):723-7. PubMed ID: 18261916 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]